0001438133-20-000139.txt : 20200904
0001438133-20-000139.hdr.sgml : 20200904
20200904164353
ACCESSION NUMBER: 0001438133-20-000139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200903
FILED AS OF DATE: 20200904
DATE AS OF CHANGE: 20200904
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HANSEN BRIAN B
CENTRAL INDEX KEY: 0001542377
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 201162216
MAIL ADDRESS:
STREET 1: 10210 GENETIC CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
4
1
wf-form4_159925221488378.xml
FORM 4
X0306
4
2020-09-03
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001542377
HANSEN BRIAN B
11075 ROSELLE ST
SAN DIEGO
CA
92121
0
1
0
0
EVP & CHIEF COMMERCIAL OFFICER
Common Stock
2020-09-03
4
M
0
9146
69.50
A
13811
D
Common Stock
2020-09-03
4
M
0
25000
18.86
A
38811
D
Common Stock
2020-09-03
4
S
0
10215
110.3238
D
28596
D
Common Stock
2020-09-03
4
S
0
23731
111.4766
D
4865
D
Common Stock
2020-09-03
4
S
0
200
112.18
D
4665
D
Common Stock
2020-09-03
4
M
0
4986
51.50
A
9651
D
Common Stock
2020-09-03
4
S
0
4986
112.8879
D
4665
D
Stock Option
69.5
2020-09-03
4
M
0
9146
0
D
Common Stock
9146.0
0
D
Stock Option
18.86
2020-09-03
4
M
0
25000
0
D
Common Stock
25000.0
0
D
Stock Option
51.5
2020-09-03
4
M
0
4986
0
D
Common Stock
4986.0
100014
D
Represents shares of common stock received upon exercise of a stock option award.
The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2020.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.78 and $110.76.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $110.78 and $111.72.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $112.18 and $112.19.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $112.75 and $113.42.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The option vested as to twenty-five percent (25%) of the underlying shares on 12/16/2017, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter.
The expiration date for these options is 10 years from the date of grant.
The option vested as to fifty percent (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter.
The option vested as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter.
s/ David B. Berger, Attorney-in-Fact for Brian B. Hansen
2020-09-04